SCHEMBL7202591

SCHEMBL7202591

CCc1c(C)[nH]c(=O)c(O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
DAO P14920 1/20 0.39
DDO Q99489 1/20 0.39
PDE3B Q13370 2/20 0.39
PDE3A Q14432 2/20 0.39
HSD17B10 Q99714 4/20 0.38
KDM4E B2RXH2 4/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
ALOX15 P16050 1/20 0.38
APOBEC3G Q9HC16 1/20 0.38
HTT P42858 1/20 0.37
MAPT P10636 2/20 0.36
STAT1 P42224 1/20 0.36
RAB9A P51151 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KDM5A P29375 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7202599 0.85 CYP1A2 (0.42) CYP1A2CYP2C19DAODDOPDE3B
SCHEMBL9846258 0.75 TYMP (0.39) CYP1A2CYP2C19PDE3BPDE3AHSD17B10
SCHEMBL7012269 0.72 GRIN2D (0.48) MAPTSMN1; SMN2MEN1KMT2A
SCHEMBL5188877 0.71 CYP1A2 (0.60) CYP1A2CYP2C19KDM4EALDH1A1HPGD
SCHEMBL3794931 0.71 KDM4E (0.64) CYP1A2CYP2C19HSD17B10KDM4EALDH1A1
SCHEMBL9846189 0.69 GRIN2D (0.45) PDE3BPDE3AHSD17B10KDM4EALDH1A1
SCHEMBL7202166 0.67 CYP1A2 (0.42) CYP1A2CYP2C19PDE3BPDE3AHSD17B10
SCHEMBL13569268 0.67 EGFR (0.35) CYP1A2CYP2C19HSD17B10KDM4EALDH1A1
SCHEMBL14423060 0.67 TYMP (0.47) CYP1A2CYP2C19PDE3BPDE3AHSD17B10
SCHEMBL891106 0.67 NPSR1 (0.54) CYP1A2CYP2C19HSD17B10KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003084538-A1 METHODS FOR TREATING ROSACEA WITH PYRIDONES MEDICIS PHARMACEUTICAL CORPORATION (US) 2003-10-16 WO disclosed